ID   HeLa-CD14
AC   CVCL_H339
SY   Hela-CD14
DR   Wikidata; Q54882712
RX   PubMed=22741009;
RX   PubMed=23086642;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
RX   PubMed=22741009; DOI=10.3892/ol.2012.557; PMCID=PMC3362372;
RA   Ning B.-T., Tang Y.-M.;
RT   "Establishment of the cell line, HeLa-CD14, transfected with the human
RT   CD14 gene.";
RL   Oncol. Lett. 3:871-874(2012).
//
RX   PubMed=23086642; DOI=10.3785/j.issn.1008-9292.2012.05.007;
RA   Ning B.-T., Song H., Yang S.-L., Xu W.-Q., Tang Y.-M.;
RT   "Establishment of a transgenic cell line with stable expression of
RT   human CD14.";
RL   Zhejiang Da Xue Xue Bao Yi Xue Ban 41:506-511(2012).
//